• Austria Fights Honey Fraud with DNA Tests, ImmVira Shows Promise Against Brain Cancer, Nanotechnology Targets Breast Cancer, New Blood Test Predicts Heart Disease, and more...

  • Apr 28 2025
  • Duración: 12 m
  • Podcast

Austria Fights Honey Fraud with DNA Tests, ImmVira Shows Promise Against Brain Cancer, Nanotechnology Targets Breast Cancer, New Blood Test Predicts Heart Disease, and more...

  • Resumen

  • (0:10): Austria Launches DNA Tests to Combat Honey Fraud Amid Rising EU Adulteration Concerns

    (2:18): ImmVira's Oncolytic Virus Shows Promise Against Aggressive Brain Cancer in Early Trials

    (4:21): Revolutionary Nanotechnology Targets Triple-Negative Breast Cancer with Precision, Reducing Side Effects

    (6:30): New Blood Test Outperforms Cholesterol Checks in Predicting Heart Disease Risk

    (8:51): Abpro and Celltrion Reveal Promising Results for New HER2-Targeted Cancer Therapy at AACR 2025

    To subscribe visit https://www.brief.news.
    For more updates in your inbox each morning visit www.brief.news.

    Image credit: Yen.com.gh
    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Austria Fights Honey Fraud with DNA Tests, ImmVira Shows Promise Against Brain Cancer, Nanotechnology Targets Breast Cancer, New Blood Test Predicts Heart Disease, and more...

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.